Parnassus Investments - Parnassus Endeavor Fund 13F Activity & Position Changes (Q4 2022)
As of Dec 31, 2022, the Parnassus Endeavor Fund portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Jan 30, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q4 2022, the filing reported:
New Buys - Advanced Micro Devices, Inc., Amazon.com, Inc., Ares Management Corporation, Astrazeneca PLC, Boston Scientific Corporation, and 16 more
Increases - Accenture plc, Autodesk, Inc., Align Technology, Inc., Applied Materials, Inc., ANSYS, Inc., and 22 more
Reductions - Agilent Technologies, Inc., Apple Inc., Abbott Laboratories, Adobe Inc., American Tower Corporation (REI, and 50 more
Complete Exits - Alnylam Pharmaceuticals, Inc., Cable One, Inc., Americold Realty Trust, Inc., Discover Financial Services, First Horizon Corporation, and 4 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q4 2022
|
A
Agilent Technologies, Inc.
|
Sell |
-311,855
|
|
Q4 2022
|
AAPL
Apple Inc.
|
Sell |
-19,603
|
|
Q4 2022
|
ABT
Abbott Laboratories
|
Sell |
-2,006,873
|
|
Q4 2022
|
ACN
Accenture plc
|
Buy |
+115,466
|
|
Q4 2022
|
ADBE
Adobe Inc.
|
Sell |
-978,869
|
|
Q4 2022
|
ADSK
Autodesk, Inc.
|
Buy |
+32,430
|
|
Q4 2022
|
ALGN
Align Technology, Inc.
|
Buy |
+421,598
|
|
Q4 2022
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
Sell - Position Exit |
-25,970
|
|
Q4 2022
|
AMAT
Applied Materials, Inc.
|
Buy |
+3,373,082
|
|
Q4 2022
|
AMD
Advanced Micro Devices, Inc.
|
Buy - Position Entry |
+3,294
|
|
Q4 2022
|
AMT
American Tower Corporation (REI
|
Sell |
-12,637
|
|
Q4 2022
|
AMZN
Amazon.com, Inc.
|
Buy - Position Entry |
+7,636
|
|
Q4 2022
|
ANSS
ANSYS, Inc.
|
Buy |
+233,659
|
|
Q4 2022
|
ARES
Ares Management Corporation
|
Buy - Position Entry |
+3,514
|
|
Q4 2022
|
AVTR
Avantor, Inc.
|
Sell |
-489,974
|
|
Q4 2022
|
AZN
Astrazeneca PLC
|
Buy - Position Entry |
+3,905
|
|
Q4 2022
|
BAC
Bank of America Corporation
|
Buy |
+25,077,300
|
|
Q4 2022
|
BALL
Ball Corporation
|
Buy |
+1,770,734
|
|
Q4 2022
|
BDX
Becton, Dickinson and Company
|
Sell |
-2,539,375
|
|
Q4 2022
|
BIIB
Biogen Inc.
|
Sell |
-41,943
|
|
Q4 2022
|
BMRN
BioMarin Pharmaceutical Inc.
|
Sell |
-227,551
|
|
Q4 2022
|
BR
Broadridge Financial Solutions,
|
Sell |
-257,900
|
|
Q4 2022
|
BSX
Boston Scientific Corporation
|
Buy - Position Entry |
+5,157
|
|
Q4 2022
|
C
Citigroup, Inc.
|
Buy - Position Entry |
+1,502,553
|
|
Q4 2022
|
CABO
Cable One, Inc.
|
Sell - Position Exit |
-83,212
|
|
Q4 2022
|
CBOE
Cboe Global Markets, Inc.
|
Sell |
-529,900
|
|
Q4 2022
|
CDNS
Cadence Design Systems, Inc.
|
Sell |
-20,554
|
|
Q4 2022
|
CHRW
C.H. Robinson Worldwide, Inc.
|
Sell |
-131,796
|
|
Q4 2022
|
CL
Colgate-Palmolive Company
|
Buy - Position Entry |
+2,697
|
|
Q4 2022
|
CMCSA
Comcast Corporation
|
Sell |
-26,172,696
|
Page 1 of 4